Intradermal Insulin Delivery
暂无分享,去创建一个
[1] J. Saaddine,et al. Achievement of goals in U.S. diabetes care, 1999-2010. , 2013, The New England journal of medicine.
[2] P. Wiffen. ENHANCED GLUCOSE CONTROL FOR PREVENTING AND TREATING DIABETIC NEUROPATHY , 2012 .
[3] A. Vaag,et al. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials , 2011, BMJ : British Medical Journal.
[4] F. Gueyffier,et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials , 2011, BMJ : British Medical Journal.
[5] P. Nilsson,et al. Glycemic Control and Cardiovascular Disease in 7,454 Patients With Type 1 Diabetes , 2010, Diabetes Care.
[6] N. Sattar,et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials , 2009, The Lancet.
[7] Mark R. Prausnitz,et al. Effect of Microneedle Design on Pain in Human Volunteers , 2008, The Clinical journal of pain.
[8] Göran Stemme,et al. Painless Drug Delivery Through Microneedle-Based Transdermal Patches Featuring Active Infusion , 2008, IEEE Transactions on Biomedical Engineering.
[9] Y Mano,et al. Painless self-monitoring of blood glucose at finger sites. , 2008, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[10] Göran Stemme,et al. Novel Microneedle Patches for Active Insulin Delivery are Efficient in Maintaining Glycaemic Control: An Initial Comparison with Subcutaneous Administration , 2007, Pharmaceutical Research.
[11] Niclas Roxhed,et al. A Fully Integrated Microneedle-based Transdermal Drug Delivery System , 2007 .
[12] N. Roxhed,et al. Compact, Seamless Integration of Active Dosing and Actuation with Microneedles for Transdermal Drug Delivery , 2006, 19th IEEE International Conference on Micro Electro Mechanical Systems.
[13] Mark R Prausnitz,et al. Precise microinjection into skin using hollow microneedles. , 2006, The Journal of investigative dermatology.
[14] Sion A. Coulman,et al. Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. , 2006, Current drug delivery.
[15] Skin Penetration of Silicon Dioxide Microneedle Arrays , 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.
[16] Wijaya Martanto,et al. Microinfusion Using Hollow Microneedles , 2006, Pharmaceutical Research.
[17] Gregory W. Sluggett,et al. EXUBERA: pharmaceutical development of a novel product for pulmonary delivery of insulin. , 2005, Diabetes technology & therapeutics.
[18] Rupak K Banerjee,et al. Evaluation of coupled convective-diffusive transport of drugs administered by intravitreal injection and controlled release implant. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[19] T. Mandal,et al. Inhaled insulin for diabetes mellitus. , 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[20] G. Stemme,et al. Reliable in-vivo penetration and transdermal injection using ultra-sharp hollow microneedles , 2005, The 13th International Conference on Solid-State Sensors, Actuators and Microsystems, 2005. Digest of Technical Papers. TRANSDUCERS '05..
[21] S. Dinh,et al. Response of the lung to pulmonary insulin dosing in the rat model and effects of changes in formulation. , 2005, Diabetes technology & therapeutics.
[22] Dorian Liepmann,et al. Clinical microneedle injection of methyl nicotinate: stratum corneum penetration , 2005, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.
[23] Mark G. Allen,et al. Hollow metal microneedles for insulin delivery to diabetic rats , 2005, IEEE Transactions on Biomedical Engineering.
[24] Mark R Prausnitz,et al. Minimally invasive extraction of dermal interstitial fluid for glucose monitoring using microneedles. , 2005, Diabetes technology & therapeutics.
[25] L. Niskanen,et al. FlexPen: addressing issues of confidence and convenience in insulin delivery. , 2005, Clinical therapeutics.
[26] S. D. Collins,et al. Microneedle array for transdermal biological fluid extraction and in situ analysis , 2004 .
[27] M. Davies,et al. The reality of glycaemic control in insulin treated diabetes: defining the clinical challenges , 2004, International Journal of Obesity.
[28] Mark R Prausnitz,et al. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. , 2004, Journal of biomechanics.
[29] Mahmoud Ameri,et al. Transdermal delivery of desmopressin using a coated microneedle array patch system. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[30] Wijaya Martanto,et al. Transdermal Delivery of Insulin Using Microneedles in Vivo , 2004, Pharmaceutical Research.
[31] M. Stumvoll,et al. [Skin changes in diabetes mellitus]. , 2004, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.
[32] R. Szeimies,et al. Hautveränderungen bei Diabetes mellitus , 2004, Der Hautarzt.
[33] A. Barnett. Exubera inhaled insulin: a review , 2004, International journal of clinical practice.
[34] M. Cormier,et al. Transdermal Delivery of Antisense Oligonucleotides with Microprojection Patch (macroflux®) Technology , 2001, Pharmaceutical Research.
[35] J. Matriano,et al. Macroflux® Microprojection Array Patch Technology: A New and Efficient Approach for Intracutaneous Immunization , 2004, Pharmaceutical Research.
[36] Mark G. Allen,et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[37] B. Zinman,et al. Alternative routes of insulin delivery , 2003, Diabetic medicine : a journal of the British Diabetic Association.
[38] M. Korytkowski,et al. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. , 2003, Clinical therapeutics.
[39] Göran Stemme,et al. Side-opened out-of-plane microneedles for microfluidic transdermal liquid transfer , 2003 .
[40] Diane E. Sutter,et al. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery , 2002, Nature Medicine.
[41] M. Allen,et al. Lack of Pain Associated with Microfabricated Microneedles , 2001, Anesthesia and analgesia.
[42] W H Smart,et al. The use of silicon microfabrication technology in painless blood glucose monitoring. , 2000, Diabetes technology & therapeutics.
[43] L. Norlén. The skin barrier : structure and physical function , 1999 .
[44] Henry,et al. Microfabricated microneedles: A novel approach to transdermal drug delivery , 1999, Journal of pharmaceutical sciences.
[45] A. Johansen,et al. Cutis/subcutis thickness at insulin injection sites and localization of simulated insulin boluses in children with Type 1 diabetes mellitus: need for individualization of injection technique? , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[46] D. Rogers,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus , 1994 .
[47] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.